Back to VRTX Stock Lookup

VRTX – Analyst PT Change

Feb 24, 2014 11:10 AM Vertex (VRTX) Target Lifted to $92 at Maxim Group
Apr 19, 2013 07:25 AM Vertex (VRTX) PT Goes to $95 at Needham & Company after Strong Data
Apr 19, 2013 07:10 AM Goldman Sachs Upgrades Vertex (VRTX) to Neutral after 661/Kalydeco Combo Data
Apr 19, 2013 06:58 AM Canaccord Genuity Upgrades Vertex (VRTX) to Buy
Dec 13, 2012 03:34 PM Goldman Says Expect More Downside in Vertex Pharmaceuticals (VRTX)
Nov 2, 2012 07:56 AM Goldman Sachs Downgrades Vertex (VRTX) to Sell; Becomes More Cautious on CF Combo Program
Sep 10, 2012 12:55 PM UBS on U.S. Biotechnology - Updating Outlook on Covered Stocks (GILD, AMGN, BIIB, CELG, INCY, IDIX, VRTX, SGEN)
Aug 17, 2012 02:54 PM Barclays Lowers Outlook on Idenix Pharmaceuticals (IDIX); Clarity on FDA Clinical Hold (BMY, VRTX, GILD)
Jul 31, 2012 01:27 PM UBS Cuts Estimates on Vertex (VRTX): Keep 'Buy' Thesis and Bullish View
May 10, 2012 08:09 AM RBC Capital Downgrades Vertex (VRTX) to Outperform
May 8, 2012 03:50 PM Leerink Swann Maintains an 'Outperform' on Vertex (VRTX); CF Conference Call Affirms Opportunity
May 8, 2012 01:47 PM Barclays Maintains an 'Overweight' on Vertex (VRTX); Raising PT to $77
May 8, 2012 07:34 AM Wells Fargo Upgrades Vertex (VRTX) to Outperform; Compelling CF Combo Data
May 7, 2012 08:59 AM ISI Group Upgrades Vertex (VRTX) to Buy
Mar 28, 2012 12:07 PM UBS Maintains a 'Neutral' on Vertex (VRTX); Potential CF Program Advancement

Back to VRTX Stock Lookup